Search Results - "Bahary, J"

Refine Results
  1. 1
  2. 2

    Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality? by BING, F, DOUCET, R, LACROIX, F, BAHARY, J. P, DARSAUT, T, ROY, D, GUILBERT, F, RAYMOND, J, WEILL, A

    Published in American journal of neuroradiology : AJNR (01-02-2012)
    “…To be radiopaque, BAVM embolization products must contain high-atomic-number materials, which may also attenuate photon beams delivered with radiosurgery. This…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy by Zilli, T, Nguyen, T.V, Bahary, J.P, Chagnon, M, Dufresne, A, Taussky, D

    Published in International Journal of Obesity (01-11-2011)
    “…Objective: We tested the potential role of abdominal visceral (VAT) and subcutaneous (SAT) adipose tissues, waist circumference (WC) and body mass index (BMI)…”
    Get full text
    Journal Article
  5. 5

    Procarbazine, lomustine and vincristine toxicity in low-grade gliomas by Jutras, G, Bélanger, K, Letarte, N, Adam, J-P, Roberge, D, Lemieux, B, Lemieux-Blanchard, É, Masucci, L, Ménard, C, Bahary, J P, Moumdjian, R, Berthelet, F, Florescu, M

    Published in Current oncology (Toronto) (01-02-2018)
    “…Procarbazine, lomustine, and vincristine (pcv) significantly improve survival outcomes in lgg (low-grade gliomas). Administration of pcv to lgg patients…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme by DEL ROWE, J, SCOTT, C, WERNER-WASIK, M, BAHARY, J. P, CURRAN, W. J, URTASUN, R. C, FISHER, B

    Published in Journal of clinical oncology (13-03-2000)
    “…This phase II study tested the efficacy and safety of tirapazamine (Sanofi Synthelabo Research, Malvern, PA), a bioreductive agent, in glioblastoma multiforme…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20